1 Scope of the Report 1.1 Market Introduction 1.2 Years Considered 1.3 Research Objectives 1.4 Market Research Methodology 1.5 Research Process and Data Source 1.6 Economic Indicators 1.7 Currency Considered 1.8 Market Estimation Caveats 2 Executive Summary 2.1 World Market Overview 2.1.1 Global Targeted Alpha-particle Therapy Market Size 2019-2030 2.1.2 Targeted Alpha-particle Therapy Market Size CAGR by Region (2019 VS 2023 VS 2030) 2.1.3 World Current & Future Analysis for Targeted Alpha-particle Therapy by Country/Region, 2019, 2023 & 2030 2.2 Targeted Alpha-particle Therapy Segment by Type 2.2.1 Actinium-225 2.2.2 Astatine-211 2.2.3 Lead-212 2.2.4 Bismuth-213 2.2.5 Others 2.3 Targeted Alpha-particle Therapy Market Size by Type 2.3.1 Targeted Alpha-particle Therapy Market Size CAGR by Type (2019 VS 2023 VS 2030) 2.3.2 Global Targeted Alpha-particle Therapy Market Size Market Share by Type (2019-2024) 2.4 Targeted Alpha-particle Therapy Segment by Application 2.4.1 Immunotherapy 2.4.2 Peritoneal Carcinomas 2.4.3 Bone Metastases 2.4.4 Leukaemia 2.4.5 Melanomas 2.4.6 Solid Tumours 2.5 Targeted Alpha-particle Therapy Market Size by Application 2.5.1 Targeted Alpha-particle Therapy Market Size CAGR by Application (2019 VS 2023 VS 2030) 2.5.2 Global Targeted Alpha-particle Therapy Market Size Market Share by Application (2019-2024) 3 Targeted Alpha-particle Therapy Market Size by Player 3.1 Targeted Alpha-particle Therapy Market Size Market Share by Player 3.1.1 Global Targeted Alpha-particle Therapy Revenue by Player (2019-2024) 3.1.2 Global Targeted Alpha-particle Therapy Revenue Market Share by Player (2019-2024) 3.2 Global Targeted Alpha-particle Therapy Key Players Head office and Products Offered 3.3 Market Concentration Rate Analysis 3.3.1 Competition Landscape Analysis 3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2022-2024) 3.4 New Products and Potential Entrants 3.5 Mergers & Acquisitions, Expansion 4 Targeted Alpha-particle Therapy by Region 4.1 Targeted Alpha-particle Therapy Market Size by Region (2019-2024) 4.2 Global Targeted Alpha-particle Therapy Annual Revenue by Country/Region (2019-2024) 4.3 Americas Targeted Alpha-particle Therapy Market Size Growth (2019-2024) 4.4 APAC Targeted Alpha-particle Therapy Market Size Growth (2019-2024) 4.5 Europe Targeted Alpha-particle Therapy Market Size Growth (2019-2024) 4.6 Middle East & Africa Targeted Alpha-particle Therapy Market Size Growth (2019-2024) 5 Americas 5.1 Americas Targeted Alpha-particle Therapy Market Size by Country (2019-2024) 5.2 Americas Targeted Alpha-particle Therapy Market Size by Type (2019-2024) 5.3 Americas Targeted Alpha-particle Therapy Market Size by Application (2019-2024) 5.4 United States 5.5 Canada 5.6 Mexico 5.7 Brazil 6 APAC 6.1 APAC Targeted Alpha-particle Therapy Market Size by Region (2019-2024) 6.2 APAC Targeted Alpha-particle Therapy Market Size by Type (2019-2024) 6.3 APAC Targeted Alpha-particle Therapy Market Size by Application (2019-2024) 6.4 China 6.5 Japan 6.6 South Korea 6.7 Southeast Asia 6.8 India 6.9 Australia 7 Europe 7.1 Europe Targeted Alpha-particle Therapy Market Size by Country (2019-2024) 7.2 Europe Targeted Alpha-particle Therapy Market Size by Type (2019-2024) 7.3 Europe Targeted Alpha-particle Therapy Market Size by Application (2019-2024) 7.4 Germany 7.5 France 7.6 UK 7.7 Italy 7.8 Russia 8 Middle East & Africa 8.1 Middle East & Africa Targeted Alpha-particle Therapy by Region (2019-2024) 8.2 Middle East & Africa Targeted Alpha-particle Therapy Market Size by Type (2019-2024) 8.3 Middle East & Africa Targeted Alpha-particle Therapy Market Size by Application (2019-2024) 8.4 Egypt 8.5 South Africa 8.6 Israel 8.7 Turkey 8.8 GCC Countries 9 Market Drivers, Challenges and Trends 9.1 Market Drivers & Growth Opportunities 9.2 Market Challenges & Risks 9.3 Industry Trends 10 Global Targeted Alpha-particle Therapy Market Forecast 10.1 Global Targeted Alpha-particle Therapy Forecast by Region (2025-2030) 10.1.1 Global Targeted Alpha-particle Therapy Forecast by Region (2025-2030) 10.1.2 Americas Targeted Alpha-particle Therapy Forecast 10.1.3 APAC Targeted Alpha-particle Therapy Forecast 10.1.4 Europe Targeted Alpha-particle Therapy Forecast 10.1.5 Middle East & Africa Targeted Alpha-particle Therapy Forecast 10.2 Americas Targeted Alpha-particle Therapy Forecast by Country (2025-2030) 10.2.1 United States Market Targeted Alpha-particle Therapy Forecast 10.2.2 Canada Market Targeted Alpha-particle Therapy Forecast 10.2.3 Mexico Market Targeted Alpha-particle Therapy Forecast 10.2.4 Brazil Market Targeted Alpha-particle Therapy Forecast 10.3 APAC Targeted Alpha-particle Therapy Forecast by Region (2025-2030) 10.3.1 China Targeted Alpha-particle Therapy Market Forecast 10.3.2 Japan Market Targeted Alpha-particle Therapy Forecast 10.3.3 Korea Market Targeted Alpha-particle Therapy Forecast 10.3.4 Southeast Asia Market Targeted Alpha-particle Therapy Forecast 10.3.5 India Market Targeted Alpha-particle Therapy Forecast 10.3.6 Australia Market Targeted Alpha-particle Therapy Forecast 10.4 Europe Targeted Alpha-particle Therapy Forecast by Country (2025-2030) 10.4.1 Germany Market Targeted Alpha-particle Therapy Forecast 10.4.2 France Market Targeted Alpha-particle Therapy Forecast 10.4.3 UK Market Targeted Alpha-particle Therapy Forecast 10.4.4 Italy Market Targeted Alpha-particle Therapy Forecast 10.4.5 Russia Market Targeted Alpha-particle Therapy Forecast 10.5 Middle East & Africa Targeted Alpha-particle Therapy Forecast by Region (2025-2030) 10.5.1 Egypt Market Targeted Alpha-particle Therapy Forecast 10.5.2 South Africa Market Targeted Alpha-particle Therapy Forecast 10.5.3 Israel Market Targeted Alpha-particle Therapy Forecast 10.5.4 Turkey Market Targeted Alpha-particle Therapy Forecast 10.6 Global Targeted Alpha-particle Therapy Forecast by Type (2025-2030) 10.7 Global Targeted Alpha-particle Therapy Forecast by Application (2025-2030) 10.7.1 GCC Countries Market Targeted Alpha-particle Therapy Forecast 11 Key Players Analysis 11.1 Bayer 11.1.1 Bayer Company Information 11.1.2 Bayer Targeted Alpha-particle Therapy Product Offered 11.1.3 Bayer Targeted Alpha-particle Therapy Revenue, Gross Margin and Market Share (2019-2024) 11.1.4 Bayer Main Business Overview 11.1.5 Bayer Latest Developments 11.2 Orano Med 11.2.1 Orano Med Company Information 11.2.2 Orano Med Targeted Alpha-particle Therapy Product Offered 11.2.3 Orano Med Targeted Alpha-particle Therapy Revenue, Gross Margin and Market Share (2019-2024) 11.2.4 Orano Med Main Business Overview 11.2.5 Orano Med Latest Developments 11.3 Oncoinvent AS 11.3.1 Oncoinvent AS Company Information 11.3.2 Oncoinvent AS Targeted Alpha-particle Therapy Product Offered 11.3.3 Oncoinvent AS Targeted Alpha-particle Therapy Revenue, Gross Margin and Market Share (2019-2024) 11.3.4 Oncoinvent AS Main Business Overview 11.3.5 Oncoinvent AS Latest Developments 11.4 Perspective Therapeutics 11.4.1 Perspective Therapeutics Company Information 11.4.2 Perspective Therapeutics Targeted Alpha-particle Therapy Product Offered 11.4.3 Perspective Therapeutics Targeted Alpha-particle Therapy Revenue, Gross Margin and Market Share (2019-2024) 11.4.4 Perspective Therapeutics Main Business Overview 11.4.5 Perspective Therapeutics Latest Developments 11.5 Ablaze Pharma 11.5.1 Ablaze Pharma Company Information 11.5.2 Ablaze Pharma Targeted Alpha-particle Therapy Product Offered 11.5.3 Ablaze Pharma Targeted Alpha-particle Therapy Revenue, Gross Margin and Market Share (2019-2024) 11.5.4 Ablaze Pharma Main Business Overview 11.5.5 Ablaze Pharma Latest Developments 11.6 ARTBIO 11.6.1 ARTBIO Company Information 11.6.2 ARTBIO Targeted Alpha-particle Therapy Product Offered 11.6.3 ARTBIO Targeted Alpha-particle Therapy Revenue, Gross Margin and Market Share (2019-2024) 11.6.4 ARTBIO Main Business Overview 11.6.5 ARTBIO Latest Developments 11.7 Fusion Pharmaceuticals(AstraZeneca) 11.7.1 Fusion Pharmaceuticals(AstraZeneca) Company Information 11.7.2 Fusion Pharmaceuticals(AstraZeneca) Targeted Alpha-particle Therapy Product Offered 11.7.3 Fusion Pharmaceuticals(AstraZeneca) Targeted Alpha-particle Therapy Revenue, Gross Margin and Market Share (2019-2024) 11.7.4 Fusion Pharmaceuticals(AstraZeneca) Main Business Overview 11.7.5 Fusion Pharmaceuticals(AstraZeneca) Latest Developments 11.8 AlphaGen Therapeutics 11.8.1 AlphaGen Therapeutics Company Information 11.8.2 AlphaGen Therapeutics Targeted Alpha-particle Therapy Product Offered 11.8.3 AlphaGen Therapeutics Targeted Alpha-particle Therapy Revenue, Gross Margin and Market Share (2019-2024) 11.8.4 AlphaGen Therapeutics Main Business Overview 11.8.5 AlphaGen Therapeutics Latest Developments 12 Research Findings and Conclusion
List of Tables Table 1. Targeted Alpha-particle Therapy Market Size CAGR by Region (2019 VS 2023 VS 2030) & ($ millions) Table 2. Targeted Alpha-particle Therapy Annual Sales CAGR by Country/Region (2019, 2023 & 2030) & ($ millions) Table 3. Major Players of Actinium-225 Table 4. Major Players of Astatine-211 Table 5. Major Players of Lead-212 Table 6. Major Players of Bismuth-213 Table 7. Major Players of Others Table 8. Targeted Alpha-particle Therapy Market Size CAGR by Type (2019 VS 2023 VS 2030) & ($ millions) Table 9. Global Targeted Alpha-particle Therapy Market Size by Type (2019-2024) & ($ millions) Table 10. Global Targeted Alpha-particle Therapy Market Size Market Share by Type (2019-2024) Table 11. Targeted Alpha-particle Therapy Market Size CAGR by Application (2019 VS 2023 VS 2030) & ($ millions) Table 12. Global Targeted Alpha-particle Therapy Market Size by Application (2019-2024) & ($ millions) Table 13. Global Targeted Alpha-particle Therapy Market Size Market Share by Application (2019-2024) Table 14. Global Targeted Alpha-particle Therapy Revenue by Player (2019-2024) & ($ millions) Table 15. Global Targeted Alpha-particle Therapy Revenue Market Share by Player (2019-2024) Table 16. Targeted Alpha-particle Therapy Key Players Head office and Products Offered Table 17. Targeted Alpha-particle Therapy Concentration Ratio (CR3, CR5 and CR10) & (2022-2024) Table 18. New Products and Potential Entrants Table 19. Mergers & Acquisitions, Expansion Table 20. Global Targeted Alpha-particle Therapy Market Size by Region (2019-2024) & ($ millions) Table 21. Global Targeted Alpha-particle Therapy Market Size Market Share by Region (2019-2024) Table 22. Global Targeted Alpha-particle Therapy Revenue by Country/Region (2019-2024) & ($ millions) Table 23. Global Targeted Alpha-particle Therapy Revenue Market Share by Country/Region (2019-2024) Table 24. Americas Targeted Alpha-particle Therapy Market Size by Country (2019-2024) & ($ millions) Table 25. Americas Targeted Alpha-particle Therapy Market Size Market Share by Country (2019-2024) Table 26. Americas Targeted Alpha-particle Therapy Market Size by Type (2019-2024) & ($ millions) Table 27. Americas Targeted Alpha-particle Therapy Market Size Market Share by Type (2019-2024) Table 28. Americas Targeted Alpha-particle Therapy Market Size by Application (2019-2024) & ($ millions) Table 29. Americas Targeted Alpha-particle Therapy Market Size Market Share by Application (2019-2024) Table 30. APAC Targeted Alpha-particle Therapy Market Size by Region (2019-2024) & ($ millions) Table 31. APAC Targeted Alpha-particle Therapy Market Size Market Share by Region (2019-2024) Table 32. APAC Targeted Alpha-particle Therapy Market Size by Type (2019-2024) & ($ millions) Table 33. APAC Targeted Alpha-particle Therapy Market Size by Application (2019-2024) & ($ millions) Table 34. Europe Targeted Alpha-particle Therapy Market Size by Country (2019-2024) & ($ millions) Table 35. Europe Targeted Alpha-particle Therapy Market Size Market Share by Country (2019-2024) Table 36. Europe Targeted Alpha-particle Therapy Market Size by Type (2019-2024) & ($ millions) Table 37. Europe Targeted Alpha-particle Therapy Market Size by Application (2019-2024) & ($ millions) Table 38. Middle East & Africa Targeted Alpha-particle Therapy Market Size by Region (2019-2024) & ($ millions) Table 39. Middle East & Africa Targeted Alpha-particle Therapy Market Size by Type (2019-2024) & ($ millions) Table 40. Middle East & Africa Targeted Alpha-particle Therapy Market Size by Application (2019-2024) & ($ millions) Table 41. Key Market Drivers & Growth Opportunities of Targeted Alpha-particle Therapy Table 42. Key Market Challenges & Risks of Targeted Alpha-particle Therapy Table 43. Key Industry Trends of Targeted Alpha-particle Therapy Table 44. Global Targeted Alpha-particle Therapy Market Size Forecast by Region (2025-2030) & ($ millions) Table 45. Global Targeted Alpha-particle Therapy Market Size Market Share Forecast by Region (2025-2030) Table 46. Global Targeted Alpha-particle Therapy Market Size Forecast by Type (2025-2030) & ($ millions) Table 47. Global Targeted Alpha-particle Therapy Market Size Forecast by Application (2025-2030) & ($ millions) Table 48. Bayer Details, Company Type, Targeted Alpha-particle Therapy Area Served and Its Competitors Table 49. Bayer Targeted Alpha-particle Therapy Product Offered Table 50. Bayer Targeted Alpha-particle Therapy Revenue ($ million), Gross Margin and Market Share (2019-2024) Table 51. Bayer Main Business Table 52. Bayer Latest Developments Table 53. Orano Med Details, Company Type, Targeted Alpha-particle Therapy Area Served and Its Competitors Table 54. Orano Med Targeted Alpha-particle Therapy Product Offered Table 55. Orano Med Targeted Alpha-particle Therapy Revenue ($ million), Gross Margin and Market Share (2019-2024) Table 56. Orano Med Main Business Table 57. Orano Med Latest Developments Table 58. Oncoinvent AS Details, Company Type, Targeted Alpha-particle Therapy Area Served and Its Competitors Table 59. Oncoinvent AS Targeted Alpha-particle Therapy Product Offered Table 60. Oncoinvent AS Targeted Alpha-particle Therapy Revenue ($ million), Gross Margin and Market Share (2019-2024) Table 61. Oncoinvent AS Main Business Table 62. Oncoinvent AS Latest Developments Table 63. Perspective Therapeutics Details, Company Type, Targeted Alpha-particle Therapy Area Served and Its Competitors Table 64. Perspective Therapeutics Targeted Alpha-particle Therapy Product Offered Table 65. Perspective Therapeutics Targeted Alpha-particle Therapy Revenue ($ million), Gross Margin and Market Share (2019-2024) Table 66. Perspective Therapeutics Main Business Table 67. Perspective Therapeutics Latest Developments Table 68. Ablaze Pharma Details, Company Type, Targeted Alpha-particle Therapy Area Served and Its Competitors Table 69. Ablaze Pharma Targeted Alpha-particle Therapy Product Offered Table 70. Ablaze Pharma Targeted Alpha-particle Therapy Revenue ($ million), Gross Margin and Market Share (2019-2024) Table 71. Ablaze Pharma Main Business Table 72. Ablaze Pharma Latest Developments Table 73. ARTBIO Details, Company Type, Targeted Alpha-particle Therapy Area Served and Its Competitors Table 74. ARTBIO Targeted Alpha-particle Therapy Product Offered Table 75. ARTBIO Targeted Alpha-particle Therapy Revenue ($ million), Gross Margin and Market Share (2019-2024) Table 76. ARTBIO Main Business Table 77. ARTBIO Latest Developments Table 78. Fusion Pharmaceuticals(AstraZeneca) Details, Company Type, Targeted Alpha-particle Therapy Area Served and Its Competitors Table 79. Fusion Pharmaceuticals(AstraZeneca) Targeted Alpha-particle Therapy Product Offered Table 80. Fusion Pharmaceuticals(AstraZeneca) Targeted Alpha-particle Therapy Revenue ($ million), Gross Margin and Market Share (2019-2024) Table 81. Fusion Pharmaceuticals(AstraZeneca) Main Business Table 82. Fusion Pharmaceuticals(AstraZeneca) Latest Developments Table 83. AlphaGen Therapeutics Details, Company Type, Targeted Alpha-particle Therapy Area Served and Its Competitors Table 84. AlphaGen Therapeutics Targeted Alpha-particle Therapy Product Offered Table 85. AlphaGen Therapeutics Targeted Alpha-particle Therapy Revenue ($ million), Gross Margin and Market Share (2019-2024) Table 86. AlphaGen Therapeutics Main Business Table 87. AlphaGen Therapeutics Latest Developments List of Figures Figure 1. Targeted Alpha-particle Therapy Report Years Considered Figure 2. Research Objectives Figure 3. Research Methodology Figure 4. Research Process and Data Source Figure 5. Global Targeted Alpha-particle Therapy Market Size Growth Rate 2019-2030 ($ millions) Figure 6. Targeted Alpha-particle Therapy Sales by Geographic Region (2019, 2023 & 2030) & ($ millions) Figure 7. Targeted Alpha-particle Therapy Sales Market Share by Country/Region (2023) Figure 8. Targeted Alpha-particle Therapy Sales Market Share by Country/Region (2019, 2023 & 2030) Figure 9. Global Targeted Alpha-particle Therapy Market Size Market Share by Type in 2023 Figure 10. Targeted Alpha-particle Therapy in Immunotherapy Figure 11. Global Targeted Alpha-particle Therapy Market: Immunotherapy (2019-2024) & ($ millions) Figure 12. Targeted Alpha-particle Therapy in Peritoneal Carcinomas Figure 13. Global Targeted Alpha-particle Therapy Market: Peritoneal Carcinomas (2019-2024) & ($ millions) Figure 14. Targeted Alpha-particle Therapy in Bone Metastases Figure 15. Global Targeted Alpha-particle Therapy Market: Bone Metastases (2019-2024) & ($ millions) Figure 16. Targeted Alpha-particle Therapy in Leukaemia Figure 17. Global Targeted Alpha-particle Therapy Market: Leukaemia (2019-2024) & ($ millions) Figure 18. Targeted Alpha-particle Therapy in Melanomas Figure 19. Global Targeted Alpha-particle Therapy Market: Melanomas (2019-2024) & ($ millions) Figure 20. Targeted Alpha-particle Therapy in Solid Tumours Figure 21. Global Targeted Alpha-particle Therapy Market: Solid Tumours (2019-2024) & ($ millions) Figure 22. Global Targeted Alpha-particle Therapy Market Size Market Share by Application in 2023 Figure 23. Global Targeted Alpha-particle Therapy Revenue Market Share by Player in 2023 Figure 24. Global Targeted Alpha-particle Therapy Market Size Market Share by Region (2019-2024) Figure 25. Americas Targeted Alpha-particle Therapy Market Size 2019-2024 ($ millions) Figure 26. APAC Targeted Alpha-particle Therapy Market Size 2019-2024 ($ millions) Figure 27. Europe Targeted Alpha-particle Therapy Market Size 2019-2024 ($ millions) Figure 28. Middle East & Africa Targeted Alpha-particle Therapy Market Size 2019-2024 ($ millions) Figure 29. Americas Targeted Alpha-particle Therapy Value Market Share by Country in 2023 Figure 30. United States Targeted Alpha-particle Therapy Market Size Growth 2019-2024 ($ millions) Figure 31. Canada Targeted Alpha-particle Therapy Market Size Growth 2019-2024 ($ millions) Figure 32. Mexico Targeted Alpha-particle Therapy Market Size Growth 2019-2024 ($ millions) Figure 33. Brazil Targeted Alpha-particle Therapy Market Size Growth 2019-2024 ($ millions) Figure 34. APAC Targeted Alpha-particle Therapy Market Size Market Share by Region in 2023 Figure 35. APAC Targeted Alpha-particle Therapy Market Size Market Share by Type (2019-2024) Figure 36. APAC Targeted Alpha-particle Therapy Market Size Market Share by Application (2019-2024) Figure 37. China Targeted Alpha-particle Therapy Market Size Growth 2019-2024 ($ millions) Figure 38. Japan Targeted Alpha-particle Therapy Market Size Growth 2019-2024 ($ millions) Figure 39. South Korea Targeted Alpha-particle Therapy Market Size Growth 2019-2024 ($ millions) Figure 40. Southeast Asia Targeted Alpha-particle Therapy Market Size Growth 2019-2024 ($ millions) Figure 41. India Targeted Alpha-particle Therapy Market Size Growth 2019-2024 ($ millions) Figure 42. Australia Targeted Alpha-particle Therapy Market Size Growth 2019-2024 ($ millions) Figure 43. Europe Targeted Alpha-particle Therapy Market Size Market Share by Country in 2023 Figure 44. Europe Targeted Alpha-particle Therapy Market Size Market Share by Type (2019-2024) Figure 45. Europe Targeted Alpha-particle Therapy Market Size Market Share by Application (2019-2024) Figure 46. Germany Targeted Alpha-particle Therapy Market Size Growth 2019-2024 ($ millions) Figure 47. France Targeted Alpha-particle Therapy Market Size Growth 2019-2024 ($ millions) Figure 48. UK Targeted Alpha-particle Therapy Market Size Growth 2019-2024 ($ millions) Figure 49. Italy Targeted Alpha-particle Therapy Market Size Growth 2019-2024 ($ millions) Figure 50. Russia Targeted Alpha-particle Therapy Market Size Growth 2019-2024 ($ millions) Figure 51. Middle East & Africa Targeted Alpha-particle Therapy Market Size Market Share by Region (2019-2024) Figure 52. Middle East & Africa Targeted Alpha-particle Therapy Market Size Market Share by Type (2019-2024) Figure 53. Middle East & Africa Targeted Alpha-particle Therapy Market Size Market Share by Application (2019-2024) Figure 54. Egypt Targeted Alpha-particle Therapy Market Size Growth 2019-2024 ($ millions) Figure 55. South Africa Targeted Alpha-particle Therapy Market Size Growth 2019-2024 ($ millions) Figure 56. Israel Targeted Alpha-particle Therapy Market Size Growth 2019-2024 ($ millions) Figure 57. Turkey Targeted Alpha-particle Therapy Market Size Growth 2019-2024 ($ millions) Figure 58. GCC Countries Targeted Alpha-particle Therapy Market Size Growth 2019-2024 ($ millions) Figure 59. Americas Targeted Alpha-particle Therapy Market Size 2025-2030 ($ millions) Figure 60. APAC Targeted Alpha-particle Therapy Market Size 2025-2030 ($ millions) Figure 61. Europe Targeted Alpha-particle Therapy Market Size 2025-2030 ($ millions) Figure 62. Middle East & Africa Targeted Alpha-particle Therapy Market Size 2025-2030 ($ millions) Figure 63. United States Targeted Alpha-particle Therapy Market Size 2025-2030 ($ millions) Figure 64. Canada Targeted Alpha-particle Therapy Market Size 2025-2030 ($ millions) Figure 65. Mexico Targeted Alpha-particle Therapy Market Size 2025-2030 ($ millions) Figure 66. Brazil Targeted Alpha-particle Therapy Market Size 2025-2030 ($ millions) Figure 67. China Targeted Alpha-particle Therapy Market Size 2025-2030 ($ millions) Figure 68. Japan Targeted Alpha-particle Therapy Market Size 2025-2030 ($ millions) Figure 69. Korea Targeted Alpha-particle Therapy Market Size 2025-2030 ($ millions) Figure 70. Southeast Asia Targeted Alpha-particle Therapy Market Size 2025-2030 ($ millions) Figure 71. India Targeted Alpha-particle Therapy Market Size 2025-2030 ($ millions) Figure 72. Australia Targeted Alpha-particle Therapy Market Size 2025-2030 ($ millions) Figure 73. Germany Targeted Alpha-particle Therapy Market Size 2025-2030 ($ millions) Figure 74. France Targeted Alpha-particle Therapy Market Size 2025-2030 ($ millions) Figure 75. UK Targeted Alpha-particle Therapy Market Size 2025-2030 ($ millions) Figure 76. Italy Targeted Alpha-particle Therapy Market Size 2025-2030 ($ millions) Figure 77. Russia Targeted Alpha-particle Therapy Market Size 2025-2030 ($ millions) Figure 78. Egypt Targeted Alpha-particle Therapy Market Size 2025-2030 ($ millions) Figure 79. South Africa Targeted Alpha-particle Therapy Market Size 2025-2030 ($ millions) Figure 80. Israel Targeted Alpha-particle Therapy Market Size 2025-2030 ($ millions) Figure 81. Turkey Targeted Alpha-particle Therapy Market Size 2025-2030 ($ millions) Figure 82. GCC Countries Targeted Alpha-particle Therapy Market Size 2025-2030 ($ millions) Figure 83. Global Targeted Alpha-particle Therapy Market Size Market Share Forecast by Type (2025-2030) Figure 84. Global Targeted Alpha-particle Therapy Market Size Market Share Forecast by Application (2025-2030)
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Bayer|||Orano Med|||Oncoinvent AS|||Perspective Therapeutics|||Ablaze Pharma|||ARTBIO|||Fusion Pharmaceuticals|||AlphaGen Therapeutics|||LP Information|||AstraZeneca